Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / SHS CL A
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
68,305
-
Shares change
-
+37,561
-
Total reported value, excl. options
-
$2,543,378
-
Value change
-
+$1,398,164
-
Number of buys
-
7
-
Number of sells
-
1
-
Price
-
$37.25
Institutional Holders of Anbio Biotechnology - SHS CL A (NNNN) as of Q3 2025
As of 30 Sep 2025 Anbio Biotechnology - SHS CL A (NNNN) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 68,305 shares of stock of the company.
Largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, XTX Topco Ltd, HRT FINANCIAL LP, BNP PARIBAS FINANCIAL MARKETS, UBS Group AG, WELLS FARGO & COMPANY/MN, and BANK OF AMERICA CORP /DE/.
This table shows 10 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.